| Source Capital, through Source Capital Credit Opportunities Fund III, LP (“SCCO III”), is pleased to announce its investment in CTL Amedica (the “Company”), a leading designer, manufacturer and distributor of spinal fusion and fixation products and tooling. SCCO III provided debt financing to recapitalize the Company and provide growth funding as the Company continues to build out its product portfolio.
Headquartered in Dallas, TX, CTL has developed a robust product portfolio of patented spinal devices, incorporating differentiated materials and surface technologies. CTL is the only company in the world that offers silicon nitride implants in spine, which has the ability to achieve superior new bone growth, along with demonstrated bacteriostatic properties and enhanced imaging attributes. CTL’s in-house engineering and manufacturing capabilities allow the Company to rapidly bring new products to the market and support hundreds of surgeons across the U.S.
“CTL has built an impressive portfolio of spinal products, and we are excited to partner with the management team and support the Company as it continues to innovate and bring new products to the market,” said Joe Rodgers, Managing Director at Source Capital.
To learn more about CTL Amedica, please visit: https://www.ctlamedica.com/ |
